124 related articles for article (PubMed ID: 37781867)
1.
Shafique R; Mahjabeen I; Bibi K; Kalsoom F; Rizwan M; Ashraf NS; Mehmood A; Ul Haq MF; Abbasi SF; Saeed N; Kayani MA
Future Oncol; 2023 Sep; 19(28):1929-1943. PubMed ID: 37781867
[No Abstract] [Full Text] [Related]
2. Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the Chinese population.
Zhao Y; Diao Y; Wang X; Lin S; Wang M; Kang H; Yang P; Dai C; Liu X; Liu K; Li S; Zhu Y; Dai Z
Oncotarget; 2016 Sep; 7(36):58174-58180. PubMed ID: 27533457
[TBL] [Abstract][Full Text] [Related]
3. [Association of mammalian target of rapamycin gene polymorphisms with the risk of pediatric epilepsy].
Yue X; Zhao PW; Liu ZS; Wu GF; Tu F; Hu JS; He XL
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):560-4. PubMed ID: 26108313
[TBL] [Abstract][Full Text] [Related]
4. Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients.
Cheng L; Qiu L; Zhang R; Qian D; Wang M; Sun M; Zhu X; Wang Y; Guo W; Wei Q
Int J Cancer; 2019 Jan; 144(2):251-262. PubMed ID: 29978580
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the effect of rs2295080 and rs2536 polymorphisms within the mTOR gene on cancer risk.
Qi GH; Wang CH; Zhang HG; Yu JG; Ding F; Song ZC; Xia QH
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32597485
[TBL] [Abstract][Full Text] [Related]
6. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
[TBL] [Abstract][Full Text] [Related]
7. Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk.
Saravani M; Shahraki-Ghadimi H; Maruei-Milan R; Mehrabani M; Mirzamohammadi S; Nematollahi MH
Mol Biol Rep; 2020 May; 47(5):3551-3556. PubMed ID: 32319007
[TBL] [Abstract][Full Text] [Related]
8. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic variants in lncRNA GAS5/miR-21/mTOR axis with risk and prognosis of coronary artery disease among a Chinese population.
Li H; Liu Y; Huang J; Liu Y; Zhu Y
J Clin Lab Anal; 2020 Oct; 34(10):e23430. PubMed ID: 32557866
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the mTOR gene and risk of sporadic prostate cancer in an Eastern Chinese population.
Li Q; Gu C; Zhu Y; Wang M; Yang Y; Wang J; Jin L; Zhu ML; Shi TY; He J; Zhou X; Ye DW; Wei Q
PLoS One; 2013; 8(8):e71968. PubMed ID: 23940798
[TBL] [Abstract][Full Text] [Related]
11. Detection of association of IL1β, IL4R, and IL6 gene polymorphisms with cervical cancer in the Bangladeshi women by tetra-primer ARMS-PCR method.
Muhammad SB; Hassan F; Bhowmik KK; Millat MS; Sarwar MS; Aziz MA; Barek MA; Sarowar Uddin M; Ferdous M; Safiqul Islam M
Int Immunopharmacol; 2021 Jan; 90():107131. PubMed ID: 33187912
[TBL] [Abstract][Full Text] [Related]
12. Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.
Logan M; Hawkins SM
Clin Sci (Lond); 2015 Feb; 128(3):153-80. PubMed ID: 25294164
[TBL] [Abstract][Full Text] [Related]
13. Correlation Between Single Nucleotide Polymorphisms of an miRNA Binding Site in the 3'UTR of
Yu A; Zhang J; Mei Y; Zhong H; Chen S; Song Q
Genet Test Mol Biomarkers; 2020 Jul; 24(7):381-389. PubMed ID: 32552146
[No Abstract] [Full Text] [Related]
14. MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer.
Wang F; Shan S; Huo Y; Xie Z; Fang Y; Qi Z; Chen F; Li Y; Sun B
Int J Biochem Cell Biol; 2018 Jun; 99():91-99. PubMed ID: 29627439
[TBL] [Abstract][Full Text] [Related]
15. Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
Yang J; Yan Z; Wang Y; Xu J; Li R; Li C; Liu S; Shi L; Yao Y
BMC Cancer; 2021 Sep; 21(1):997. PubMed ID: 34488676
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-22 in female malignancies: Focusing on breast, cervical, and ovarian cancers.
Nejati K; Alivand M; Arabzadeh A
Pathol Res Pract; 2021 Jul; 223():153452. PubMed ID: 33993061
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic variations in mTOR with risk of childhood acute lymphoblastic leukemia in a Chinese population.
Huang L; Huang J; Wu P; Li Q; Rong L; Xue Y; Lu Q; Li J; Tong N; Wang M; Zhang Z; Fang Y
Leuk Lymphoma; 2012 May; 53(5):947-51. PubMed ID: 21973240
[TBL] [Abstract][Full Text] [Related]
18. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in miRNA binding sites and miRNA genes as breast/ovarian cancer risk modifiers in Jewish high-risk women.
Kontorovich T; Levy A; Korostishevsky M; Nir U; Friedman E
Int J Cancer; 2010 Aug; 127(3):589-97. PubMed ID: 19950226
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of mTOR and cancer risk: a systematic review and updated meta-analysis.
Zining J; Lu X; Caiyun H; Yuan Y
Oncotarget; 2016 Aug; 7(35):57464-57480. PubMed ID: 27462867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
